Based on these anti-inflammatory mechanisms of A20 and evidence of its capacity for arthritic inhibition discussed above, we suggest that A20 is a potential target for arthritis therapies, with the advantages of its multipath effect on arthritis pathogenesis. This evidence concerns the gene TNFAIP3 and arthritic joint disease.